IMCC
Price
$2.56
Change
+$0.05 (+1.99%)
Updated
Aug 7 closing price
Capitalization
10.21M
SCYX
Price
$0.88
Change
+$0.17 (+23.94%)
Updated
Aug 7 closing price
Capitalization
55.88M
10 days until earnings call
Interact to see
Advertisement

IMCC vs SCYX

Header iconIMCC vs SCYX Comparison
Open Charts IMCC vs SCYXBanner chart's image
IM Cannabis
Price$2.56
Change+$0.05 (+1.99%)
Volume$44.28K
Capitalization10.21M
SCYNEXIS
Price$0.88
Change+$0.17 (+23.94%)
Volume$978.93K
Capitalization55.88M
IMCC vs SCYX Comparison Chart in %
Loading...
IMCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMCC vs. SCYX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMCC is a Hold and SCYX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (IMCC: $2.56 vs. SCYX: $0.88)
Brand notoriety: IMCC and SCYX are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: IMCC: 43% vs. SCYX: 561%
Market capitalization -- IMCC: $10.21M vs. SCYX: $55.88M
IMCC [@Pharmaceuticals: Other] is valued at $10.21M. SCYX’s [@Pharmaceuticals: Other] market capitalization is $55.88M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMCC’s FA Score shows that 0 FA rating(s) are green whileSCYX’s FA Score has 0 green FA rating(s).

  • IMCC’s FA Score: 0 green, 5 red.
  • SCYX’s FA Score: 0 green, 5 red.
According to our system of comparison, IMCC is a better buy in the long-term than SCYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMCC’s TA Score shows that 2 TA indicator(s) are bullish while SCYX’s TA Score has 5 bullish TA indicator(s).

  • IMCC’s TA Score: 2 bullish, 7 bearish.
  • SCYX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SCYX is a better buy in the short-term than IMCC.

Price Growth

IMCC (@Pharmaceuticals: Other) experienced а -2.29% price change this week, while SCYX (@Pharmaceuticals: Other) price change was +26.79% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.12%. For the same industry, the average monthly price growth was +73.14%, and the average quarterly price growth was +82.67%.

Reported Earning Dates

SCYX is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.12% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SCYX($55.9M) has a higher market cap than IMCC($10.2M). IMCC YTD gains are higher at: 9.819 vs. SCYX (-27.686). SCYX has higher annual earnings (EBITDA): 70.9M vs. IMCC (-17.09M). SCYX has more cash in the bank: 74.4M vs. IMCC (1.3M). IMCC has less debt than SCYX: IMCC (11.7M) vs SCYX (15.1M). SCYX has higher revenues than IMCC: SCYX (140M) vs IMCC (52.5M).
IMCCSCYXIMCC / SCYX
Capitalization10.2M55.9M18%
EBITDA-17.09M70.9M-24%
Gain YTD9.819-27.686-35%
P/E RatioN/A1.06-
Revenue52.5M140M38%
Total Cash1.3M74.4M2%
Total Debt11.7M15.1M77%
FUNDAMENTALS RATINGS
SCYX: Fundamental Ratings
SCYX
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
15

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMCCSCYX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
68%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
IMCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NMR6.950.07
+1.02%
Nomura Holdings
GBDC14.73-0.06
-0.37%
Golub Capital BDC
IBIO0.59N/A
-0.47%
iBio
FCBC35.21-0.74
-2.06%
First Community Bankshares
MAPS0.90-0.05
-5.35%
WM Technology

IMCC and

Correlation & Price change

A.I.dvisor tells us that IMCC and CRON have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMCC and CRON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMCC
1D Price
Change %
IMCC100%
+1.99%
CRON - IMCC
25%
Poorly correlated
+8.10%
SHIEF - IMCC
25%
Poorly correlated
N/A
DVAX - IMCC
23%
Poorly correlated
-1.16%
SCYX - IMCC
22%
Poorly correlated
+23.41%
SNDL - IMCC
22%
Poorly correlated
-1.18%
More

SCYX and

Correlation & Price change

A.I.dvisor tells us that SCYX and AQST have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCYX and AQST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCYX
1D Price
Change %
SCYX100%
+23.41%
AQST - SCYX
33%
Poorly correlated
-1.50%
TLRY - SCYX
30%
Poorly correlated
+5.40%
AKAN - SCYX
29%
Poorly correlated
+20.56%
CRDL - SCYX
28%
Poorly correlated
+1.40%
ACET - SCYX
27%
Poorly correlated
-1.97%
More